PuSH - Publication Server of Helmholtz Zentrum München: What shall we do with the damaged proteins in lung disease? Ask the proteasome!

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Meiners, S. ; Eickelberg, O.

What shall we do with the damaged proteins in lung disease? Ask the proteasome!

Eur. Respir. J. 40, 1260-1268 (2012)

Publ. Version/Full Text Volltext

DOI

PMC

	Closed

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

The proteasome constitutes the main protein waste disposal and recycling system of the cell. Together with the endoplasmatic reticulum (ER) stress and the autophagosome pathway, it also takes centre stage in cellular protein quality control. In lung research, the proteasome is - first of all - a promising therapeutic target to intervene with malignant growth of lung cancer cells. Therapeutic targeting of the proteasome has also been extended to pulmonary fibrosis and asthma, using animal models. Moreover, the proteasome is involved in lung pathogenesis: In cystic fibrosis, rapid proteasomal degradation of mutant cystic fibrosis transmembrane regulator contributes to loss of function of lung epithelial cells. In chronic obstructive pulmonary disease (COPD), pulmonary proteasome expression and activity is downregulated and inversely correlates with lung function. In addition, as the proteasome degrades signaling mediators that have been oxidatively modified in COPD, it contributes to further compromise cellular function. The consequences of proteasomal dysfunction are loss of protein quality control, accumulation of misfolded proteins, and exacerbation of cellular stress, which are also hallmarks of protein quality diseases and premature aging. This suggests that proteasome dysfunction can be regarded as a new pathomechanism for chronic lung diseases, awaiting further therapeutic exploration in the future.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

5.895

2.270